We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allergan plc | NYSE:AGN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 193.02 | 0 | 01:00:00 |
TIDM0QCV TIDM0Y7T FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) State Street Global Advisors & Affiliates --------------------------------------------- ------------------------------- Company dealt in AbbVie Inc. --------------------------------------------- ------------------------------- Class of relevant security to which US$0.01 common stock the dealings being disclosed relate (Note 2) --------------------------------------------- ------------------------------- Date of dealing 04(th) March 2020 --------------------------------------------- ------------------------------- 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short ------------------------------------- -------------------- ----------- Number (%) Number (%) ------------------------------------- ---------- -------- ------ --- (1) Relevant securities 67,369,661 4.54444% ------------------------------------- ---------- -------- ------ --- (2) Derivatives (other than options) N/A ------------------------------------- ---------- -------- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------- ---------- -------- ------ --- Total 67,369,661 4.54444% ------------------------------------- ---------- -------- ------ --- (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short ------------------------------------------- ----------- ----------- Number (%) Number (%) ------------------------------------------- ------ --- ------ --- (1) Relevant securities N/A ------------------------------------------- ------ --- ------ --- (2) Derivatives (other than options) N/A ------------------------------------------- ------ --- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------------- ------ --- ------ --- Total N/A ------------------------------------------- ------ --- ------ --- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) -------------- ----------------------------- ----------------------- Purchase 800 91.75 -------------- ----------------------------- ----------------------- Purchase 200 91.75 -------------- ----------------------------- ----------------------- Purchase 1,700 91.75 -------------- ----------------------------- ----------------------- Purchase 1,700 91.75 -------------- ----------------------------- ----------------------- Purchase 3,100 91.75 -------------- ----------------------------- ----------------------- Purchase 600 89.84 -------------- ----------------------------- ----------------------- Purchase 500 91.75 -------------- ----------------------------- ----------------------- Purchase 3,400 91.75 -------------- ----------------------------- ----------------------- Purchase 1,800 91.29 -------------- ----------------------------- ----------------------- Purchase 1,000 91.75 -------------- ----------------------------- ----------------------- Purchase 2,300 91.75 -------------- ----------------------------- ----------------------- Purchase 3,256 91.75 -------------- ----------------------------- ----------------------- Purchase 12,446 91.75 -------------- ----------------------------- ----------------------- Purchase 51,792 91.75 -------------- ----------------------------- ----------------------- Purchase 348 91.75 -------------- ----------------------------- ----------------------- Purchase 1,160 91.75 -------------- ----------------------------- ----------------------- Purchase 291 91.75 -------------- ----------------------------- ----------------------- Purchase 16,956 91.75 -------------- ----------------------------- ----------------------- Purchase 3,297 91.75 -------------- ----------------------------- ----------------------- Purchase 630 91.75 -------------- ----------------------------- ----------------------- Purchase 2,600 91.75 -------------- ----------------------------- ----------------------- Purchase 704 91.75 -------------- ----------------------------- ----------------------- Purchase 704 91.75 -------------- ----------------------------- ----------------------- Purchase 1,950 91.75 -------------- ----------------------------- ----------------------- Purchase 975 91.75 -------------- ----------------------------- ----------------------- Purchase 1,686 91.75 -------------- ----------------------------- ----------------------- Purchase 2,440 91.75 -------------- ----------------------------- ----------------------- Purchase 103 89.93 -------------- ----------------------------- ----------------------- Purchase 17 90.49 -------------- ----------------------------- ----------------------- Sale 2,300 91.75 -------------- ----------------------------- ----------------------- Sale 3,100 91.75 -------------- ----------------------------- ----------------------- Sale 5,815 91.75 -------------- ----------------------------- ----------------------- Sale 1,000 91.75 -------------- ----------------------------- ----------------------- Sale 3,400 91.75 -------------- ----------------------------- ----------------------- Sale 500 91.75 -------------- ----------------------------- ----------------------- Sale 6 91.75 -------------- ----------------------------- ----------------------- Sale 1,700 91.75 -------------- ----------------------------- ----------------------- Sale 202 91.75 -------------- ----------------------------- ----------------------- Sale 1,260 91.75 -------------- ----------------------------- ----------------------- Sale 1,707 91.75 -------------- ----------------------------- ----------------------- Sale 1,036 91.75 -------------- ----------------------------- ----------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) ------------- --------------------- ----------------------------- -------------- N/A ------------- --------------------- ----------------------------- -------------- (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money e.g. call option purchasing securities to which price American, date paid/received varying etc. the option relates European etc. per unit (Note 5) (Note 7) ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ N/A ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ (ii) Exercising
Product name, Number of securities Exercise price per e.g. call option unit (Note 5) ----------------- -------------------- ------------------ N/A ----------------- -------------------- ------------------ (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) --------------------- ------- ------------------------- N/A --------------------- ------- ------------------------- 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ----------------------------------------------------------- N/A ----------------------------------------------------------- Is a Supplemental Form 8 attached? (Note 9) NO ------------------------------------------------------- ----------------- Date of disclosure 05(th) March 2020 ------------------------------------------------------- ----------------- Contact name Lionel Colaco ------------------------------------------------------- ----------------- Telephone number 020 33956098 ------------------------------------------------------- ----------------- If a connected EFM, name of offeree/offeror with which N/A connected ------------------------------------------------------- ----------------- If a connected EFM, state nature of connection (Note N/A 10) ------------------------------------------------------- ----------------- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION Name of person dealing (Note 1) State Street Global Advisors & Affiliates --------------------------------------------- ------------------------------- Company dealt in AbbVie Inc. --------------------------------------------- ------------------------------- Class of relevant security to which US$0.01 common stock the dealings being disclosed relate (Note 2) --------------------------------------------- ------------------------------- Date of dealing 03(rd) March 2020 --------------------------------------------- ------------------------------- 2. INTERESTS AND SHORT POSITIONS (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short ------------------------------------- -------------------- ----------- Number (%) Number (%) ------------------------------------- ---------- -------- ------ --- (1) Relevant securities 67,273,232 4.54699% ------------------------------------- ---------- -------- ------ --- (2) Derivatives (other than options) N/A ------------------------------------- ---------- -------- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------- ---------- -------- ------ --- Total 67,273,232 4.54699% ------------------------------------- ---------- -------- ------ --- (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short ------------------------------------------- ----------- ----------- Number (%) Number (%) ------------------------------------------- ------ --- ------ --- (1) Relevant securities N/A ------------------------------------------- ------ --- ------ --- (2) Derivatives (other than options) N/A ------------------------------------------- ------ --- ------ --- (3) Options and agreements to purchase/sell N/A ------------------------------------------- ------ --- ------ --- Total N/A ------------------------------------------- ------ --- ------ --- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant securities Price per unit (Note 5) -------------- ----------------------------- ----------------------- Purchase 300 87.57 -------------- ----------------------------- ----------------------- Purchase 800 87.57 -------------- ----------------------------- ----------------------- Purchase 782 88.07 -------------- ----------------------------- ----------------------- Purchase 400 87.57 -------------- ----------------------------- ----------------------- Purchase 700 87.57 -------------- ----------------------------- ----------------------- Purchase 6,100 87.57 -------------- ----------------------------- ----------------------- Purchase 2,500 87.57 -------------- ----------------------------- ----------------------- Purchase 8,500 87.57 -------------- ----------------------------- ----------------------- Purchase 3,500 87.57 -------------- ----------------------------- ----------------------- Purchase 1,480 87.57 -------------- ----------------------------- ----------------------- Purchase 119,126 87.57 -------------- ----------------------------- ----------------------- Purchase 125,349 87.57 -------------- ----------------------------- ----------------------- Purchase 11,952 87.57 -------------- ----------------------------- ----------------------- Purchase 1,624 87.57 -------------- ----------------------------- ----------------------- Purchase 1,843 87.57 -------------- ----------------------------- ----------------------- Purchase 3,800 90.18 -------------- ----------------------------- ----------------------- Purchase 450 87.57 -------------- ----------------------------- ----------------------- Purchase 500 87.57 -------------- ----------------------------- ----------------------- Purchase 315 87.57 -------------- ----------------------------- ----------------------- Purchase 800 87.57 -------------- ----------------------------- ----------------------- Purchase 500 87.57 -------------- ----------------------------- ----------------------- Purchase 974 87.57 -------------- ----------------------------- ----------------------- Purchase 153 87.19 -------------- ----------------------------- ----------------------- Purchase 1,100 87.57 -------------- ----------------------------- ----------------------- Purchase 544 87.57 -------------- ----------------------------- ----------------------- Sale 8,500 87.57 -------------- ----------------------------- ----------------------- Sale 500 87.57 -------------- ----------------------------- ----------------------- Sale 800 87.57 -------------- ----------------------------- ----------------------- Sale 2,500 87.57 -------------- ----------------------------- ----------------------- Sale 300 88.20 -------------- ----------------------------- ----------------------- Sale 1,212 87.57 -------------- ----------------------------- ----------------------- Sale 13,188 87.57 -------------- ----------------------------- ----------------------- Sale 10,072 87.57 -------------- ----------------------------- ----------------------- Sale 156 87.57 -------------- ----------------------------- ----------------------- Sale 3,500 87.57
-------------- ----------------------------- ----------------------- Sale 6,100 87.57 -------------- ----------------------------- ----------------------- Sale 1,072 87.57 -------------- ----------------------------- ----------------------- Sale 569 87.57 -------------- ----------------------------- ----------------------- Sale 569 87.57 -------------- ----------------------------- ----------------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) ------------- --------------------- ----------------------------- -------------- N/A ------------- --------------------- ----------------------------- -------------- (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money e.g. call option purchasing securities to which price American, date paid/received varying etc. the option relates European etc. per unit (Note 5) (Note 7) ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ N/A ----------------- ----------------- -------------------- -------- -------------- ------ ------------------ (ii) Exercising Product name, Number of securities Exercise price per e.g. call option unit (Note 5) ----------------- -------------------- ------------------ N/A ----------------- -------------------- ------------------ (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) --------------------- ------- ------------------------- N/A --------------------- ------- ------------------------- 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ----------------------------------------------------------- N/A ----------------------------------------------------------- Is a Supplemental Form 8 attached? (Note 9) NO ------------------------------------------------------- ----------------- Date of disclosure 04(th) March 2020 ------------------------------------------------------- ----------------- Contact name Lionel Colaco ------------------------------------------------------- ----------------- Telephone number 020 33956098 ------------------------------------------------------- ----------------- If a connected EFM, name of offeree/offeror with which N/A connected ------------------------------------------------------- ----------------- If a connected EFM, state nature of connection (Note N/A 10) ------------------------------------------------------- -----------------
(END) Dow Jones Newswires
March 05, 2020 10:15 ET (15:15 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions